The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Establishes leading platform of multi-omic technologies with the highest throughput and highest data quality to power clinical research insights Expands commercial reach with substantial cross-selling ...
Hosted on MSN
Standard BioTools outlines $165M-$175M revenue target for FY2025 while driving proteomics partnerships
CEO Michael Egholm highlighted that Standard BioTools delivered Q1 2025 revenues of $40.8 million, aligned with their plan despite a challenging operating backdrop. He emphasized improvements in ...
Standard BioTools (NASDAQ:LAB) will release its quarterly earnings report on Tuesday, 2026-02-24. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Standard BioTools ...
SomaLogic Inc.’s SLGC stock was up about 12% in premarket trades on Wednesday after the Boulder, Colo.-based specialist in cell proteins agreed to be acquired in an all-stock merger with Standard ...
BOSTON, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the "Company” or "Standard BioTools”) today announced financial results for the quarter and fiscal year ended ...
The Dow Jones index closed higher by around 0.2% on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company’s prospects. Investors and traders ...
Zacks Investment Research on MSN
Standard BioTools (LAB) reports Q1 loss, tops revenue estimates
Standard BioTools (LAB) came out with a quarterly loss of $0.02 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.04 per share a year ago. These figures are adjusted ...
Ninety posters and presentations at AACR powered by the Standard BioTools (LAB) proteomic portfolio to advance cancer research from target discovery to clinical development SOUTH SAN FRANCISCO, Calif.
Standard BioTools expects the restructuring costs to be paid over the next several months. The company indicated that the operational changes are intended to support the execution of its long-term ...
The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results